View drug registration information details.
| Items | Registration information |
|---|
| ID | 437 |
|---|
| No | 437 |
|---|
| Brand Name | BEZARTAN TABLET 150 MG |
|---|
| Ingredients | IRBESARTAN 150 MG |
|---|
| Dosage Form | FILM COATED TABLET |
|---|
| Primary Packaging | PVDC-BLISTER |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 3 X 10'S |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | TREATMENT OF ESSENTIAL HYPERTENSION, TREATMENT OF DIABETIC NEPHROPATHY WITH AN ELEVATED SERUM CREATININE AND PROTEINURIA (>300 MG/DAY) IN PATIENTS WITH TYPE 2 DIABETES AND HYPERTENSION |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | WHITE TO OFF WHITE, BICONVEX, OVAL-SHAPED, WITH MARKING " 150" ON ONE SIDE AND FILM COATED TABLET. |
|---|
| Note | |
|---|
| License Owner | DKSH LAOS COMPANY LIMITED |
|---|
| Manufacturer | DUOPHARMA MANUFACTURING(BANGI)SDN.BHD. |
|---|
| Country | MALAYSIA |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 04 I 5475/23 |
|---|
| FDD Registration Date | 25-APR-2023 |
|---|
| Expiry Date | 24-APR-2026 |
|---|
Back to drug list
|
